Navigation Links
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
Date:11/9/2009

ROCKVILLE, Md., Nov. 9 /PRNewswire/ -- OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics. "Generating high quality mono-specific antibodies in a high throughput manner is critical for the success of the program," commented Prof Mathias Uhlen, Program Director. "In a pilot testing using OriGene's over-expression cell lysates as Western blot positive controls, we were able to increase antibody validation success rate from 30% to 80%. We are extremely happy with the results and have decided to adopt these lysates in the official Human Protein Atlas program." Dr. Wei-Wu He, CEO of OriGene Technologies, commented, "We are honored to team up with a world renowned researcher like Prof. Uhlen. OriGene has built the most comprehensive cDNA clone collection. These over-expression lysates are the beginning of a series of products aimed at antibody validation and biomarker discovery. We are committed to provide both products and technical resource required by the Human Protein Atlas project."

About OriGene

OriGene Technologies, Inc., is a gene centric life sciences tool company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene's novel product line includes the world's largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is committed to its mission to be "Your Gene Company", in supplying everything a researcher would need for gene based research. For more information, visit www.origene.com.

SOURCE OriGene Technologies, Inc.


'/>"/>
SOURCE OriGene Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
3. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
4. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
7. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
8. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
9. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
10. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Jan. 23, 2017  Allergan plc, (NYSE: AGN ... support of the International Headache Academy (IHA). Designed to inspire ... research scientists, IHA offers a three-day, intensive overview on research ... has been the sole sponsor since the inception of IHA ... iHEAD in Europe in 2014. ...
(Date:1/23/2017)... , Jan. 23, 2017  Using Astute Medical,s ... high risk for acute kidney injury (AKI) after ... globally-recognized care guidelines significantly improved outcomes ... AKI more than 33 percent, according to a ... journal Intensive Care Medicine. ...
(Date:1/23/2017)... YORK , January 23, 2017 ... Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX ), Sophiris Bio ... MNTA ), and Agile Therapeutics Inc. (NASDAQ: ... sector which turned somewhat lower in late trade on Friday, ... Index dropping about 0.3%, while shares of health care companies ...
Breaking Medicine Technology:
(Date:1/24/2017)... , ... January 24, 2017 , ... “Speaking With God’s ... With God’s Voice” is the creation of published author, Louis A. Miraglia, a born-again ... how best to deliver God’s great, impactful Word. , “There is little doubt ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: a ... Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor of Word ... bachelor degree in religious education and a master degree in theology. , ““The Octagon ...
(Date:1/24/2017)... ... 2017 , ... OSF Ventures, the corporate investment arm of ... headquartered in Silicon Valley that connects startups to corporations and invests in more ... agreement to be a corporate sponsor of Plug and Play’s program for Health ...
(Date:1/24/2017)... (PRWEB) , ... January 23, 2017 , ... ... men who support them, Dr. Carol Francis, Psychologist in the South Bay ... pay, humane respectful governing for all people and by all people shines as ...
(Date:1/23/2017)... Alto, CA (PRWEB) , ... ... ... a provider of translation and localization services for life science companies, has ... and inspection organization, TÜV SÜD America. ISO 17100 is the globally recognized ...
Breaking Medicine News(10 mins):